-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Nu.Q ® Capture-Mass spectrometry – novel proteomics approach to epigenetic profiling of circulating nucleosomes
- Share
- Tweet
- Share on Facebook
- Share
Poster title: Nu.Q® Capture-Mass spectrometry is a novel proteomics approach to epigenetic profiling of circulating nucleosomes.
Presented at EEHD 2022
Van den Ackerveken et al
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields